{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:24Z","timestamp":1791928764855,"version":"4.3.4"},"reference-count":29,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,10,18]]},"DOI":"10.1167\/iovs.62.13.12","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:18:54Z","timestamp":1634750334000},"page":"12","source":"Crossref","is-referenced-by-count":11,"title":["The Intraocular Pressure Lowering Effect of a Dual Kinase Inhibitor (ITRI-E-(S)4046) in Ocular Hypertensive Animal Models"],"prefix":"10.1167","volume":"62","author":[{"given":"Yi-Hsun","family":"Chen","sequence":"first","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"},{"name":"Institute of NanoEngineering and MicroSystems (iNEMS), National Tsing Hua University, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Chuan","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center, Taipei, Taiwan"},{"name":"Department of Research and Development, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yu","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Fu","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Mu","family":"Tu","sequence":"additional","affiliation":[{"name":"Institute of NanoEngineering and MicroSystems (iNEMS), National Tsing Hua University, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrong-Shiong","family":"Hwang","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Lien","family":"Hung","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chun","family":"Lin","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Cheng","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Jen","family":"Wang","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Chen","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Hsiang","family":"Chou","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ping","family":"She","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Cheng","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"1","key":"bib1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"bib2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"bib3","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1038\/srep19640","article-title":"Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40265-018-0877-7","article-title":"Netarsudil Ophthalmic Solution 0.02%: First Global Approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"bib5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","article-title":"Rho kinase (ROCK) inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"bib6","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"issue":"1-2","key":"bib7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"bib8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2013.2100","article-title":"Rho\/Rho-associated kinase pathway in glaucoma (Review)","volume":"43","author":"Wang","year":"2013","journal-title":"Int J Oncol"},{"issue":"3","key":"bib9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1083\/jcb.200306172","article-title":"Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts","volume":"164","author":"Totsukawa","year":"2004","journal-title":"J Cell Biol"},{"issue":"2","key":"bib10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/exer.2002.2009","article-title":"A Myosin Light Chain Kinase Inhibitor, ML-9, Lowers the Intraocular Pressure in Rabbit Eyes","volume":"75","author":"Honjo","year":"2002","journal-title":"Exp Eye Res"},{"issue":"3","key":"bib12","first-page":"101","article-title":"Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature","volume":"7","author":"Moshirfar","year":"2018","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"6","key":"bib13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1586\/eop.11.65","article-title":"Rho kinase inhibitors for treatment of glaucoma","volume":"6","author":"Mandell","year":"2011","journal-title":"Expert Rev Ophthalmol"},{"issue":"5","key":"bib14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2013.2100","article-title":"Rho\/Rho-associated kinase pathway in glaucoma (Review)","volume":"43","author":"Wang","year":"2013","journal-title":"Int J Oncol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13065-018-0414-5","article-title":"Development and validation of an HPLC\u2013MS\/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study","volume":"12","author":"Alrabiah","year":"2018","journal-title":"Chemistry Central Journal"},{"issue":"12","key":"bib16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/1744666X.2021.1850269","article-title":"Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn's disease","volume":"16","author":"Yao","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2012.06526.x","article-title":"Myosin light chain kinase: pulling the strings of epithelial tight junction function","volume":"1258","author":"Cunningham","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"19","key":"bib18","doi-asserted-by":"publisher","first-page":"10339","DOI":"10.1073\/pnas.2001250117","article-title":"Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis","volume":"117","author":"van Zyl","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"bib19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2165\/11634460-000000000-00000","article-title":"Intraocular pressure-lowering combination therapies with prostaglandin analogues","volume":"72","author":"Aptel","year":"2012","journal-title":"Drugs"},{"key":"bib20","first-page":"1","article-title":"Considerations in glaucoma therapy: fixed combinations versus their component medications","volume":"4","author":"Higginbotham","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"bib21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology"},{"issue":"2","key":"bib22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archophthalmol.2009.384","article-title":"Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study","volume":"128","author":"Higginbotham","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"bib23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1185\/03007990903498786","article-title":"Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension","volume":"26","author":"Orme","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"bib24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/aos.13790","article-title":"Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study","volume":"96","author":"Lind\u00e9n","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/s41598-019-40255-9","article-title":"Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial","volume":"9","author":"Sakamoto","year":"2019","journal-title":"Sci Rep"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/aos.2016.94.issue-1","article-title":"One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension","volume":"94","author":"Tanihara","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/s41598-019-40255-9","article-title":"Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial","volume":"9","author":"Sakamoto","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"bib29","doi-asserted-by":"publisher","first-page":"e39269","DOI":"10.1371\/journal.pone.0039269","article-title":"Dynamic regulation of myosin light chain phosphorylation by Rho-kinase","volume":"7","author":"Kaneko-Kawano","year":"2012","journal-title":"PLoS One"},{"key":"bib11","article-title":"Test No. 405: Acute Eye Irritation\/Corrosion","author":"Organsation for Economic Co-operation and Development (OECD)","year":"2020"},{"key":"bib25","first-page":"549","article-title":"Chapter 44 - Drugs used in ocular treatment","volume-title":"Side Effects of Drugs Annual","author":"Stottlemyer","year":"2019"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2777991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:23Z","timestamp":1791927083000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2777991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":29,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,10,4]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.13.12","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}